Erratum {#Sec1}
=======

Following the publication of our article \[[@CR1]\], we noticed that some incorrect images had been incorporated into figure twoB (included here as Fig. [1b](#Fig1){ref-type="fig"}) and threeF-H (included here as Fig. [2f-h](#Fig2){ref-type="fig"}) in error. The corrected figures are given below. This correction does not change the results or conclusion of the original study.Fig. 1Identification of human parthenogenetic embryonic stem cells. **a** Colony of human parthenogenetic embryonic stem cells; (**b**) positive staining for alkaline phosphatase; **(c)** normal 46, XX karyotype at passage 20; (**d**) positive staining for OCT4; (**e**) positive staining for NANOG; (**f**) positive staining for TRA-1-60; (D1-F1) nuclear staining with Hoechst 33342; (D2-F2) merged images for OCT4, NANOG and TRA-1-60. Bar is 100 μmFig. 2Differentiation abilities of human parthenogenetic embryonic stem cells. *In vitro* differentiated EBs displayed (**a**) positive AFP staining (endoderm), (**b**) positive SMA staining (mesoderm), (**c**) positive TUBULIN staining (ectoderm), and (**d**) expression of genes from endoderm (NF68KD), mesoderm (HBZ) and ectoderm (Albumin). Bar is 50 μm. (**e**) Efficiency of teratoma formation upon injection of human parthenogenetic embryonic stem cells into SCID mice; (**f**) neuro-ectoderm from ectoderm in teratoma; (**g**) cartilage from mesoderm in teratoma; (**h**) glandular tissue from endoderm in teratoma. Bar is 100 μm. EB, embryoid bodies; SCID, severe combined immunodeficiency

The online version of the original article can be found under doi:10.1186/s13287-015-0054-9.
